Smith & Nephew PLC

SN.

Company Profile

  • Business description

    Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

  • Contact

    Hatters Lane
    Building 5, Croxley Park
    WatfordHertfordshireWD18 8YE
    GBR

    T: +44 1923477100

    E: [email protected]

    https://www.smith-nephew.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    16,988

Stocks News & Analysis

stocks

Investors again disappointed by ASX bank result

Solid result but valuation is stretched.
stocks

Big-four bank earnings surge but revenue growth elusive

Shares sell off after results.
stocks

This ASX supermarkets business is now underperforming its largest competitor

Competition restrains long-term margins.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.8030.30-0.34%
CAC 407,976.12138.72-1.71%
DAX 4023,991.27301.11-1.24%
Dow JONES (US)48,941.90557.37-1.13%
FTSE 10010,363.9314.89-0.14%
HKSE26,095.88319.351.24%
NASDAQ25,067.8046.64-0.19%
Nikkei 22559,513.12228.200.38%
NZX 50 Index13,020.3777.31-0.59%
S&P 5007,200.7529.37-0.41%
S&P/ASX 2008,697.1028.50-0.33%
SSE Composite Index4,112.164.650.11%

Market Movers